Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Jun 5;9(43):27171–27196. doi: 10.18632/oncotarget.25506

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2018 Abouelghar et al.

This is an open-access article distributed under the terms of the Creative Commons Attribution License 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

(A) Percentages of the NK-activating ligands whose high mRNA expression significantly associated (Favorable and Worse) or not (N.S.) with RFS (Left graph) or OS (Right graph) in the different lymph node (LN) statuses. “Favorable“ indicates the association of high mRNA expression with longer RFS/OS, representing good prognosis. “Worse” indicates the association of the high mRNA expression with shorter RFS/OS, representing bad prognosis. “N.S.” indicates no significant association with prognosis. (B) Individual value plots visualizing the distribution of the hazard ratio (HR) values of the NK-activating ligands in LN negative and LN positive BC patients. The bars represent the median, lower and higher HR values for all ligands in each subtype.